#InMode

Thiard News@F4F

@newsen.bsky.social

1 day ago

InMode Launches New Share Repurchase Initiative to Strengthen Shareholder Value and Maintain Market Position InMode Ltd. has unveiled a share repurchase program targeting up to 10% of its outstanding shares, demonstrating confidence in its financial health and market position.

InMode Launches New Share Repurchase Initiative to Strengthen Shareholder Value and Maintain Market Position #Israel #share_repurchase #Financial_Strategy #Yokneam #InMode

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

InMode Concludes Transaction Committee Review, Focuses on Growth Strategies InMode Ltd. has completed its independent transaction committee review, finding no proposals aligned with its best interests, while focusing on growth strategies.

InMode Concludes Transaction Committee Review, Focuses on Growth Strategies #Israel #Yokneam #Medical_Technologies #InMode #Nasdaq_INMD

Thiard News@F4F

@newsen.bsky.social

1 month ago

InMode Releases Fourth Quarter and Full Year 2025 Financial Performance Results with GAAP Revenue Trends InMode Ltd. unveils its financial outcomes for Q4 and FY 2025, highlighting revenue shifts and strategic outlook for growth.

InMode Releases Fourth Quarter and Full Year 2025 Financial Performance Results with GAAP Revenue Trends #Israel #financial_results #medical_technology #Yokneam #InMode

Thiard News@F4F

@newsen.bsky.social

1 month ago

InMode Set to Showcase Innovations at the 13th Annual BTIG MedTech Conference InMode Ltd. announces its participation in the 13th Annual BTIG Conference featuring investor meetings led by CFO Yair Malca in Snowbird, Utah.

InMode Set to Showcase Innovations at the 13th Annual BTIG MedTech Conference #United_States #Medical_Technologies #InMode #Snowbird #BTIG_Conference

Thiard News@F4F

@newsen.bsky.social

1 month ago

InMode Ltd. Addresses Recent Acquisition Rumors and Strategic Review Process InMode Ltd. publicly addresses acquisition rumors and outlines its ongoing strategic review process, reassuring investors about future prospects.

InMode Ltd. Addresses Recent Acquisition Rumors and Strategic Review Process #Israel #Steel_Partners #Yokneam #InMode #INMD

𝕞𝕚𝕟𝕞𝕚 ℂ𝕝𝕚𝕟𝕚𝕔 𝕆𝕗𝕗𝕚𝕔𝕚𝕒𝕝 | 美容クリニック | 韓国皮膚科

@minmijapan.bsky.social

2 months ago

【衝撃のBefore→After💫】
たった1日でこの変化！

Vラインパッケージ
✓インモードFX(下顔面)
✓Vシュリンク200S
✓フェイスカット注射10cc
+
✓顎フィラー1cc(単品追加)

4つの相乗効果で理想の小顔へ✨

動画で確認👆

LINE▶
@minmijapan

📍新論峴駅7番出口
📍江南駅10番出口

#ミエンミクリニック #Vライン #小顔 #インモード #InMode #Vシュリンク #フェイスカット注射 #顎フィラー #ChinFiller #リフトアップ #FaceLift #二重顎改善 #フェイスライン #韓国美容 #KBeauty

Thiard News@F4F

@newsen.bsky.social

3 months ago

Insights from a Recent Survey on InMode and Facial Treatments A survey revealing insights on InMode treatments shows a significant satisfaction rate among users, with facial procedures being the most popular choice.

Insights from a Recent Survey on InMode and Facial Treatments #Japan #Tokyo #InMode #Facial_Treatment #Beauty_Clinic

Thiard News@F4F

@newsen.bsky.social

4 months ago

InMode's Q3 2025 Financial Results: A Detailed Overview of Revenue and Growth Prospects InMode has released its financial results for Q3 2025, reporting a revenue of $93.2 million, a drop from last year but a solid gross margin of 78%.

InMode's Q3 2025 Financial Results: A Detailed Overview of Revenue and Growth Prospects #NASDAQ #Israel #financial_results #Yokneam #InMode

Thiard News@F4F

@newsen.bsky.social

4 months ago

InMode Japan Receives Approval for Mophius Pro Medical Device to Enhance Aesthetic Skin Treatment InMode Japan has recently announced the acquisition of manufacturing and sales approval for the Mophius Pro medical device, designed for fractional resurfacing.

InMode Japan Receives Approval for Mophius Pro Medical Device to Enhance Aesthetic Skin Treatment #Japan #Tokyo #Medical_Device #InMode #Mophius_Pro

Thiard News@F4F

@newsen.bsky.social

6 months ago

DOMA Perpetual Calls on InMode Board to Prioritize Capital Return to Shareholders DOMA Perpetual Capital Management urges the Board of InMode Ltd. to enact share buybacks, asserting fiduciary duties to shareholders.

DOMA Perpetual Calls on InMode Board to Prioritize Capital Return to Shareholders #USA #Miami #DOMA_Perpetual #InMode #Stock_Buybacks

Thiard News@F4F

@newsen.bsky.social

6 months ago

InMode Announces Participation at Baird 2025 Global Healthcare Conference in New York InMode Ltd. confirms its participation in the Baird 2025 Global Healthcare Conference on September 10, presenting innovative medical technologies and strategic insights.

InMode Announces Participation at Baird 2025 Global Healthcare Conference in New York #New_York #Israel #Healthcare_Conference #Medical_Technologies #InMode

Thiard News@F4F

@newsen.bsky.social

9 months ago

InMode's CEO Addresses Shareholder Concerns in Response Letter to DOMA InMode's CEO Moshe Mizrahy responds to letter from DOMA's Pedro Escudero, addressing key shareholder concerns about the company's strategies.

InMode's CEO Addresses Shareholder Concerns in Response Letter to DOMA #InMode #DOMA #Moshe_Mizrahy

Thiard News@F4F

@newsen.bsky.social

9 months ago

InMode Achieves Health Canada Certification for IgniteRF Platform with QuantumRF Technology InMode Ltd. proudly announces the Health Canada certification of IgniteRF, integrating advanced QuantumRF technology for innovative, minimally invasive treatments.

InMode Achieves Health Canada Certification for IgniteRF Platform with QuantumRF Technology #Canada #Yokneam #InMode #QuantumRF #IgniteRF

Thiard News@F4F

@newsen.bsky.social

10 months ago

InMode Secures Court Injunction Against Counterfeit Morpheus8 Devices to Safeguard Patients InMode Ltd. has secured a permanent injunction against counterfeit Morpheus8 devices, enhancing safety and trademark protection. The ruling aids in consumer protection and authorized provider recognition.

InMode Secures Court Injunction Against Counterfeit Morpheus8 Devices to Safeguard Patients #USA #Irvine #medical_technology #InMode #Morpheus8

Thiard News@F4F

@newsen.bsky.social

1 year ago

InMode's Response to DOMA Perpetual: Clarifying Capital Strategies and Management Practices InMode Ltd. addresses the concerns raised by DOMA Perpetual regarding its capital allocation and management practices, reaffirming its commitment to shareholder value.

InMode's Response to DOMA Perpetual: Clarifying Capital Strategies and Management Practices #Israel #Yokneam #Medical_Technologies #InMode #DOMA

Thiard News@F4F

@newsen.bsky.social

1 year ago

InMode's Participation in Upcoming Investor Conferences Highlighting Innovative Medical Technologies InMode Ltd. announces its participation in key investor conferences in March to showcase innovative medical technologies and engage with stakeholders.

InMode's Participation in Upcoming Investor Conferences Highlighting Innovative Medical Technologies #Israel #Investor_Conferences #Yokneam #Medical_Technologies #InMode

Thiard News@F4F

@newsen.bsky.social

1 year ago

Revolutionary Skin Tightening Technology by Dr. Elie Levine in NYC Dr. Elie Levine, a renowned plastic surgeon in New York, introduces the innovative Quantum RF Skin Tightening technology for exceptional results in aesthetic treatments.

Revolutionary Skin Tightening Technology by Dr. Elie Levine in NYC #United_States #New_York #Elie_Levine #Quantum_RF #InMode

Thiard News@F4F

@newsen.bsky.social

1 year ago

InMode to Engage Investors at BTIG MedTech Conference in Snowbird, Utah InMode Ltd. announces participation in the BTIG MedTech Conference, inviting investors to engage with CFO Yair Malca on February 12, 2025.

InMode to Engage Investors at BTIG MedTech Conference in Snowbird, Utah #United_States #MedTech #Ltd #InMode #Snowbird

Good Optometry Morning: Dr. Michael Nelson

@eyecaremadesimple.bsky.social

1 year ago

Radiofrequency (RF) Cure for Dry Eye – What to Know YouTube video by GOOD OPTOMETRY MORNING: Eye Care Made Simple

Radiofrequency is an fantastic treatment for dry eye with a unique side effect that you will love.

#inmode #dryeye

youtu.be/Weu6UqUFpRM

LetMoneyWork

@letmoneywork.bsky.social

2 years ago

#Inmode nach Gewinnwarnung im Minus. Bewertung sieht fair aus. Ich kann aber das Geschäft nicht abschätzen. #Pharma #Aktien haben es zurzeit aber auch nicht ganz einfach.
Letztlich aber die Zeiten wo man in der Branche nach Perlen suchen kann.